StockIQ.techBio-Techne Corporation (TECH) Stock Analysis
Free AI-powered analysis and research for Bio-Techne Corporation stock
Sector: Healthcare
TECH snapshot
Data as of 3 Nov 2026 close. Updated daily.
Bio-Techne Corporation scores 71/100 on StockIQ's model, which reads as positive signals overall. The price is above its 200-day average and at 100% of its 52-week range, up 18.7% over the past year. Latest reported figures show a profit margin of 15.0%, return on equity of 9.0% and revenue growth of +1.3%.
What is driving the score
- RSI Neutral: +5
- Flat Trend: +1
- MACD Bearish: -8
- High P/E (62.7): -10
- Good Profit Margin (15.0%): +5
- Low Debt (0.14 D/E): +8
- Strong Liquidity (4.55 Current Ratio): +8
- High P/B (5.38): -5
- Strong Long-term Uptrend: +8
- Healthy Momentum (+18.7% over 1 year): +7
- Low Volume (0.4x): -3
- Near 52-Week High (100%): +5
Automated, general information only – not financial advice. Scores can be wrong. How the score works
Full TECH report
Bio-Techne Corporation (TECH) is listed in the Healthcare sector. The snapshot on this page updates daily; run a full report for the complete breakdown.
Analyze TECH Now →📰 Latest Update
Why Is Techne (TECH) Down 0.1% Since Last Earnings Report?
Fri, September 11, 2026 at 3:30 PM UTC 2 min read
Techne Corporation (TECH) experienced a slight decline of 0.1% since its last earnings report, which revealed mixed results that fell short of analyst expectations. This dip may concern investors as it highlights potential challenges in revenue growth and market demand. Monitoring future performance and strategic initiatives will be crucial for assessing Techne's ability to regain momentum and deliver value to shareholders.